European Urology

Article	Citations
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer	1141
Manfred Wirth – A life devoted to urology in a time of change	1092
Editorial Board	608
The Platinum Hall of Fame	551
More Than Words: Defining Adjuvant, Consolidative, and Salvage Treatment after Radical Prostatectomy	535
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial	504
Honing Stratification and Treatment for High-risk Prostate Cancer	468
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma	384
Re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature	372
Editorial Board	328
Prostate Cancer Active Surveillance Without Biopsy? Not Quite Yet, but Watch This Space	313
Reply to Nour Khalil, Guiseppe Maiolino, and Eric Barret’s Letter to the Editor re: Rui M. Bernardino, Theodorus van der Kwast, Neil E. Fleshner. Intraductal Carcinoma and Cribriform Pattern in Prosta	249
P266 – From stones to strokes: How calcium kidney stones signal carotid atherosclerosis through oxidative stress	239
P082 – Age disparity in couples seeking first medical help for infertility has changed over the last twenty years: A sociological study	221
P203 – Systemic immune inflammation and stress urinary incontinence	190
A0546 – The diagnostic potential of the penile cavernous density measurement by ultrasound	178
P639 – Site-specific differences of eligibility for adjuvant immunotherapy among urothelial carcinoma patients treated with radical surgery: Results of a multicenter cohort study	176
A0459 – Is there an oncological benefit of extended pelvic lymph node dissection at the time of radical prostatectomy in PSMA-PET node negative prostate cancer patients? Results from a multi-instituti	169
A0519 – Efficacy and tolerability of androgen receptor targeted agents (ARTAs) in patients with metastatic castration-resistant prostate cancer (mCRPC) in different treatment sequences	164
V115 – Management of pelvic vessels injury during robotic pelvic urooncology procedures	155
A0248 – Natural and assisted conceptions in young men treated for hematological cancer who stored their semen for fertility preservation	153
A0872 – Real-world experience and long-term survival of high-risk non-muscle invasive bladder cancer treated with BCG: 5-year outcomes from a large UK tertiary referral centre	144
A0228 – A randomized controlled trial comparison of stent-related symptoms between anti-reflux stents and standard double-J stents in school-age children	133
P369 – Predictors of intraoperative conversion from robotic to open radical cystectomy and effects on patients survival	128
P410 – Perioperative and oncological outcomes of incomplete thermal ablations with or without immediate retreatment for patients with small renal masses	124

P505 – The role of prostate-specific antigen after cryotherapy for primary localized prostate cancer	119
P190 – The impact of radiographic disappearance of metastases as a new surrogate marker for therapy in patients with metastatic hormone-sensitive prostate cancer	113
A0150 – Enrolment of racial and ethnic minority group patients in contemporary non-prostate cancer urological clinical trials: A systematic review	113
GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial)	113
P225 – Effect of preoperative urine culture timing on postoperative outcomes of retrograde intrarenal surgery: Preliminary results of the RIRSearch study	111
A0759 – Vecto® prostate biopsy: 4-year outcomes of novel MRI-US fusion, transperineal prostate biopsies under local anaesthesia, utilising electromagnetic needle tracking	110
A0484 – Endourology clinic: Artificial intelligence vs. natural intelligence	104
A0607 – What is the optimal BCR-free survival cut-off predicting favourable long-term outcomes? A multicenter retrospective EMPaCT study	102
A0622 – Single-port nerve-sparing radical prostatectomy – initial learning curve of a high-volume multi-port surgeon	99
A0634 – Evaluation of Salvage High Intensity Focused Ultrasound (S-HIFU) and hemi-S-HIFU for radiorecurrent prostate cancer	97
A0276 – OPUS program: Organized prostate cancer screening in Mexico	97
P393 – Identification, validation and pathway enrichment analysis of differentially expressed genes and miRNAs as diagnostic biomarkers in clear cell renal cell carcinoma	96
A0493 – Updated meta-analysis of VI-RADS score in image-guided assessment of muscle invasiveness in bladder cancer Pre-TURBT	92
A0611 – Prediction of prostate cancer biochemical recurrence by a specific collagen-related proteo-transcriptomics signature	92
A0321 – Definition of risk categories for urethral stricture recurrence after free graft bulbar urethroplasty using classification and regression tree analysis	91
A0492 – Adopting stone volume instead of maximum stone diameter: Worth it or an academic fantasy? Results from a worldwide survey	91
A0866 – A randomized, open-label, controlled clinical study to assess the digital health application INKA in the management of therapy refractory overactive bladder and mixed incontinence	89
A0347 – The genotype-phenotype association in von Hippel-Lindau (VHL) disease with the codon 167 missense mutations: A large retrospective study/a population-based study	89
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided	87
Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?	87
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade	85
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update	85
Prostate-Specific Antigen Screening in Transgender Patients	83
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinica	82
Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential	82
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial	79
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. 2025;87:340–341	77
Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robot	77
A0486 – Comparison of 1-mm vs. 0.5-mm thick reconstructed images to evaluate residual stone fragments and dust particles: An evaluation using porcine kidneys	76
P033 – Is the routine histological analysis of paediatric foreskin specimens following a circumcision justified?	74
A0100 – Day care PCNL: Who Qualifies? Introducing the day-care PCNL checklist	73
A0796 – Cost-effectiveness analysis of treatments for BCG-unresponsive high-risk NMIBC	72
P526 – Single port versus multiport robotic nephroureterectomy with bladder cuff exicision: Comparative study for initial cases	72
A0078 – IP8-FLUORESCE: A prospective paired-cohort study evaluating fluorescence confocal microscopy for rapid evaluation of surgical margins in radical prostatectomy	72
A0677 – Bladder EpiCheck triggered photodynamic diagnosis biopsies detect high grade recurrences missed by white light cystoscopy	71
P219 – The quality of life of pregnant patients after active and delayed endourological treatment of urolithiasis	70
P213 – The influence of STAT1 butyrylation in the prostate transition zone on benign prostatic hyperplasia via the NOTCH1/ATF3 pathway	70
Acknowledgement to Reviewers	69
P547 – Genomic insights into intraductal carcinoma of the prostate from the Genomic Umbrella Neoadjuvant Study (GUNS) in high-risk localized prostate cancer	69
Re: W. Marston Linehan, Cathy Anne Pinto, Yanfang Liu, et al. Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease. Eur Urol 2025;88:56–63	69
Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Random	68
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy	67
Reply to Laurence Klotz’s Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels” in Major Urology	66
Congress Calendar	65
Delayed absent ejaculation in men presenting to the fertility clinic – retrospective cohort study	65
The impact of adjuvant chemotherapy on overall survival in patients with node-positive Upper Tract Urothelial Carcinoma (UTUC): Improving precision in medicine with a risk-stratified approach	62
SWL is more cost-effective than fURS for the management of kidney stones: Comparative study in a tertiary care centre	62
Comparing urine and stone microbiome in urolithiasis patients	61
Re: Association of Black Race with Prostate Cancer–specific and Other-cause Mortality	61
Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study	60

A randomized controlled trial comparing 1470nm diode laser vs. plasmakinetic enucleation of the prostate for treating benign prostatic hyperplasia	60
The complications of synthetic mid-urethral slings: The discrepancy between demographic data and clinical trials- a systematic review with meta-analysis	60
Utility of robotic platform for upper and mid ureteric reconstruction: Our experience at MPUH, Nadiad	60
The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain	59
Hsa_circ_0005221 promotes prostate cancer progression through miR-339-5p/ STAT5a	59
Intravesical injection with abobotulinumtoxin-A in patients with bladder pain syndrome/ interstitial cystitis	59
Gender disparities in editorial board of academic urology journals	58
First clinical experience with a novel approach of robot-assisted completely retroperitoneal nephroureterectomy with bladder cuff	57
Spontaneous passage rate of ureteral stones and predictive factors after pre-stenting	57
Efficacy of tamsulosin versus mirabegron for ureteric stent related symptoms: Prospective randomized questionnaire based comparison	57
The feasibility and advantages of an at-home intravesical therapy service for benign conditions	56
The surgical learning curve for cancer control after robot-assisted radical prostatectomy	56
Comparison of clinical outcomes after phalloplasty with versus without urethral lengthening in transgender men	56
Management of renal cell carcinoma in transplant kidney: An individual patient data meta-analysis and evidence-based guide	54
Evaluation of the effect of umbilical cord derived urethral slings in bilateral pudendal nerves injury-induced urinary incontinence in female rats	54
The effect of duration between sessions on biofeedback treatment in children with dysfunctional voiding	53
Do patients prefer telecommunication to traditional face-to face clinic review: A benefit of covid-19?	53
Efficacy of recombinant Bacillus Calmette-Guérin–dltA in three-dimensional bioprinted bladder cancer-on-a-chip with microfluidic system	53
Outcomes according to histological variants of urothelial carcinoma after neoadjuvant chemotherapy in the GETUG-AFU V05 VESPER trial	53
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors	52
Editorial Board	52
Prenatal exposure to SSRI antidepressants and time of neonatal first void - A case control study	51
Qualitative assessment of patient-reported outcomes in urinary and sexual function in patient after perineal urethrostomy	51
Development of an individual postoperative prediction model for kidney cancer recurrence using machine learning (UroCCR study 120)	51
MRI/US fusion targeted prostate biopsies koelis®: Impact of operator experience on clinicaly significant prostate cancer detection	51
Surgical and oncologic outcomes of surgery in early metastatic seminoma: Multi-institutional retrospective study	51
Radiomics-based prognostic model guided by artificial intelligence to predict lymph node invasion and biochemical recurrence in patients with high-grade prostate cancer	50
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials	50
De-escalation of monitoring for prostate cancer active surveillance: Results of the GAP3 consortium	50
LEST: Anatomical ablative ejaculation sparing surgery for BPH	49
Immunoprophyaxis with MV-140 is effective in the prevention of urinary tract infections – results of a prospective study	49
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma	48
What are the optimal laser settings for stone dusting using the popcorn technique	48
Mechanism of cystine stone growth revealed by ultrastructural observation using scanning electron microscopy	48
Re: Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes	47
Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy	46
Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase	46
Photodynamic diagnosis (PDD) directed biopsies vs white light bladder mapping in patients with positive cytology and negative preoperative workup: An international multicenter retrospective study. On	45
Risk factors for postoperative infections after urological surgery: Preliminary results from the national and multicenter TOCUS study	45
Prostatectomy vs. radiotherapy for regional node positive prostate cancer	45
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma	45
Erogenous and aversive sensation throughout the vulva, vagina, and breasts in cis-gender women: Anatomic heat-map to assess effect of treatment on erogenous sensation	43
Development and validation of a new personalized algorithmic model for PSA analysis : PROSTia	43
Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) scoring system: A two-reader, two-centre study	43
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups	43
Is testosterone replacement therapy effective and safe even for eugonadal men with symptom of late onset hypogonadism?	43
Re-treatment for Lower Urinary Tract Symptoms (LUTS) after water vapor thermal therapy	42
Reclassification of small renal masses according to the EAU Guidelines newly-proposed TNM classification for suspected renal cell carcinoma: Implications for decision-making	42
Assessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study	42
More micrometastases, more recurrence? Assessing the role of quantitative rtPCR of PSA from lymph nodes post-prostatectomy in predicting biochemical recurrence - an experimental study	42
Incidental prostate cancer in patients treated for benign prostatic hyperplasia: Analysis from a contemporary national dataset	41
Quantitative MRI parameters providing the novel value in discriminating muscle-invasive bladder cancer	41
Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study	40
Prognostic value of circulating tumor cells and cell-free DNA in upper tract urothelial carcinoma	40
Robot-assisted radical prostatectomy for prostate cancer: 18-year oncological outcomes from a Belgian high-volume center	39
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?	39
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study	39
18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging	38
Which men with cN1 prostate cancer at PSMA PET/CT represent the ideal candidate for radical prostatectomy? Development of a novel risk stratification tool for individualized approaches based on a larg	38
Transcriptomic analysis of the lncRNA-miRNA-mRNA axis network in aldosterone-producing adenoma	38
Congress Calendar	38
Incontinence in boys and girls following succesful primary closure of bladder extrophy: Management with orthotopic ileal neobladder and costruction of anterior intrapelvic neourethra derived from detr	38
100 years of history-making urology – the Portuguese urology association	38
Igloo-technique for robotic radical prostatectomy — maximum nerve sparing for early recovery of continence and sexual function	37
Outcomes of urethroplasty (UP), 10 years after surgery	37
A comprehensive in vitro assessment of thulium fiber laser in soft tissues and stones	37
Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression	37
Fosfomycin for antibiotic prophylaxis in men undergoing a transrectal prostate biopsy: A systematic review and meta-analysis	36
Clinicopathological correlate of urine 8-hydroxydeoxyguanosine levels in patients with prostate biopsy	36
Minimally invasive cytoreductive nephrectomy for metastatic renal cell carcinoma in the immunotherapy era: Results from the REMARC-IO database	36
Bladder EpiCheck methylation test predicts short- and long-term HG events in bladder cancer patients treated with bacillus Calmette-Guérin	35
Contents	35
Propensity-score matched survival analysis of octogenarians with muscle-invasive bladder cancer: Chemoradiation compared to radical cystectomy	34
Surgical outcomes of robot-assisted radical prostatectomy with the novel HUGO™ robotic system: Initial 100 cases performed at a tertiary referral robotic center	34
The development of a hollow three-dimensional kidney spheroid model for the study of calcium-containing crystal formation	34
Rezūm water vapour therapy (Rezūm): Is it safe to continue antiplatelet or anticoagulation medication?	34
Cumulative thulium fiber laser energy and stone-free rates: Outcomes from the team of worldwide endourological researchers (TOWER) thulium fiber laser registry	34
Protein-based molecular subtypes associate with clinical-pathological characteristics in a multi-institutional cohort of upper tract urothelial carcinomas	34
Contents	33
Tumors of the Urinary System and Male Genital Organs: 2022 World Health Organization Classification and Multidisciplinarity	33

Re: Bhavan P. Rai, José Luis Dominguez Escrig, Luís Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.	33
Improved survival in contemporary actively treated community-based metastatic clear-cell renal cell carcinoma patients	32
Prostate cancer prevention clinic for men with risk of familial prostate cancer (profam-risk)	31
Efficacy and safety of darolutamide in combination with androgen-deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial	31
The Platinum Hall of Fame	31
Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer	31
Efficacy and safety of low-dose tadalafil compared to tolterodine and placebo in females with overactive bladder symptoms. A prospective double blind controlled study	31
Single-port vs. multi-port robot-assisted partial nephrectomy: A single center propensity-score matched analysis	31
Sutureless robot assisted partial nephrectomy: Feasibility and surgical technique (UroCCR n°158)	31
AI-based classification and segmentation method for bladder cancer from cystoscopic image: Preliminary study	30
Impact of radical prostatectomy on pelvic floor muscles: An electromyography and perineometric assessment	30
Multi-centre study comparing outcomes of RIRS using traditional suction ureteral access sheath (SUAS) and flexible-navigable suction UAS (FANS)	30
Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction	30
Head to head comparison between RENAL and PADUA nephrometry scores in predicting TRIFECTA achievement in off-clamp Robot-assisted partial nephrectomy	29
Retzius-sparing robot-assisted radical prostatectomy for large prostate volumes: Surgical and functional outcomes	29
Real-world cost for first-line treatment for prostate cancer: A comparative cost analysis in the public sector	29
Urolithiasis in patients with kidney transplantation: Multicenter KSER research series	28
Non-infectious adverse events of transperineal prostate biopsies performed under local anesthesia in an outpatient setting – results from the NORAPP study – a randomized clinical trial	28
Orificial surgery at the turn of the 20th century: Not exactly a precursor of current NOTES, but another embarrassing chapter in the history of modern surgery	28
Radiomics model to predict teratoma in metastatic non-seminomatous testicular germ cell tumors	28
Minimally invasive adrenalectomy for the treatment of malignant adrenal metastasis: Results from two high volume centers	28
Robot-assisted video-endoscopic radical inguinal lymphadenectomy for penile cancer: surgical anatomy and technique	28
Guidewire-marking before robotic salvage lymph node dissection for in-field lymph node recurrences after radical prostatectomy: Initial experiences	28
Short-term morbidity and long-term functional outcomes of the T-plasty for salvage reconstruction of recalcitrant bladder neck stenosis	27
Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome:	27
First-in-human experience with the LithoVueTM elite single use ureteroscope: Can intrarenal pressure be manipulated?	27
Comparison of two different approaches in the management of infants with primaryobstructive megaureters and their long-term outcomes	27
Functional and endoscopic results up to two years after Aquablation for BPH-related LUTS: A single centre first clinical experience	27
Strengths and weaknesses of using Optum Clinformatics Data Mart to study in-vitro fertilization	27
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: A meta-analysis	27
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination The	27
3D laparoscopic versus robot assisted laparoscopic prostatectomy, a randomized prospective study. Preliminary 1-year functional results	27
Validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents	26
The next generation trial: Assessing 18F-PSMA-1007 positron emission tomography and magnetic resonance imaging in the primary staging of prostate cancer patients	26
The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance	26
Salvage focal ablation versus radical prostatectomy for localized radiorecurrent prostate cancer: A propensity-score matched comparison	26
Impact of systemic therapy in clinical T1 small-cell neuroendocrine carcinoma of the bladder	26
Persistently elevated urinary inflammatory biomarkers may predict recurrence of recurrent urinary tract infection in women	26
Prospective randomized comparison of SP TFL and Ho:YAG in RIRS for kidney stones: a single-center study	25
Replacing ReTUR with Cystoscopy in High-Grade T1 NMIBC patients: Confirmatory results from the HuNIRe Trial	25
A prospective paired comparison trial on mirabegron and anticholinergics in patients with low bladder compliance	25
Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort	25
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer	25
Efficacy of sacral nerve modulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis	25
Incremental value of machine learning-based radiomics for preoperative discrimination between malignant and benign small renal masses	25
What is new at the deepest point of human civilization for andrologic point of view?	25
Epidermal growth factor-like domain 7 inhibit immune response in metastatic castration resistant prostate cancer by de-activation of endothelial intercellular adhesion molecule-1	25
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution	25
Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the	24
Re: The Prognostic Value of p53 and Ki-67 Expression Status in Penile Cancer: A Systematic Review and Meta-analysis	24
Re: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis	24
Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Ph	24
Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Cu	24
Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0.	24
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder	24
Re: Nicolaus F. Debatin, Elena Bady, Tim Mandelkow, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. Eur Urol. 2024;86:42–51	24
Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association	24
Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor	24
Contents	24
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Tria	24
Role of Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Seminoma: Recommendations from the European Association of Urology Guidelines Panel on Testicular Cancer	23
Refining the Tissue Source for Biomarker-based Approaches in Renal Cell Carcinoma	23
Re: Massimiliano Creta, Giorgio I. Russo, Naeem Bhojani, et al. Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Sugg	23
P327 – Risk-based screen and prognostic analysis for second primary malignancies in patients with renal cell carcinoma: A retrospective cohort study based on large-scale population and mendelian rando	22
Re: Male-partner Treatment to Prevent Recurrence of Bacterial Vaginosis	22
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort	22
A0727 – To stent or not to stent? Comparison of postoperative complications among patients undergoing radical cystectomy	22
A0764 – Cadonilimab combined with lenvatinib for neoadjuvant therapy in early-stage renal cell carcinoma with indications for partial nephrectomy but high surgical risk: A prospective single-arm phase	22
Re: A New Technique for the Treatment of Ureteric Stricture After Kidney Transplantation	22
Re: Lucia L. Rijstenberg, Hridya Harikumara, Esther I. Verhoef, et al. Identification of Intraductal-to-Invasive Spatial Transitions in Prostate Cancer: Proposal for a New Unifying Model on Intraducta	22
P580 – The accuracy of PSMA-PET/CT in the preoperative staging of intermediate-unfavourable and high-risk prostate cancer patients	22
P250 – Clinically significant residual stones after retrograde intrarenal surgery: Early results of a 5-year follow-up, RIRSearch group study	22
Retroperitoneal Robotic Partial Nephrectomy with the Hugo RAS System	22
A0504 – A non-coding RNA based classifier for favorable outcomes in clinically organ confined bladder cancer patients undergoing radical cystectomy surgery	22
P558 – Simultaneous in situ urinary extracellular vesicle mRNA and protein content detection with a novel self-amplified CRISPR-Cas13a system for non-invasive early diagnosis of bladder cancer	21
P507 – Natural history for patients undergoing transoerineal fusion biopsies to transperineal fusion cryoablation	21
V124 – Retrosigmoid ileal conduit: A new approach to reduce incidence of benign ureteroenteric strictures	21
A0531 – Comparison of the predictive value of mpMRI and PSMA PET/CT for pelvic lymph node metastasis in prostate cancer	21
A0613 – Impact of different persistent prostate-specific antigen values on oncological outcomes after radical prostatectomy	21
V031 – Retroperitoneal robot-assisted laparoscopic partial adrenalectomy in prone position for adrenal pheochromocytoma	21
P465 – A randomized placebo-controlled comparison of prolonged-release Sildenafil with a standard Sildenafil	21
A0218 – EAU recommendations for the diagnosis and treatment of genital Herpes Simplex Virus (HSV)	20
A0610 – Added value of pathological stage and nodal status to EAU biochemical recurrence risk groups in predicting metastatic progression after radical prostatectomy	20
A0262 – Indocyanine green fluorescence guidance alone is not able to replace radioactivity guidance during sentinel node biopsy for penile cancer	20
V016 – The reconstruction of severe type hypospadias with sandwich technique and double-stents device – sharing the experience in recent 30 years	19
V019 – Feasibility and perioperative outcomes of single-port nephroureterectomy with supine anterior retroperitoneal approach: A technique to respect all oncological principles of urothelial cancers	19
P427 – Robot-assisted posterior urethral reconstruction with quantitative three-dimensional reconstruction for the treatment of male traumatic urethral atresia following complex pelvic fractures: The	19
P630 – Pelvic organ-sparing robot-assisted radical cystectomy in women with bladder cancer	19
A0557 – Management of priapism and its impact on outcomes: An international register (MARS study) – the first international, multicenter, observational study regarding priapism	19
A0574 – Collective optilume BPH 2-year clinical outcomes: Combined experience from the pivotal PINNACLE and EVEREST prospective clinical studies	19
P602 – In patients with muscle invasive bladder cancer undergoing radical cystectomy, dynamics of ctDNA post-cystectomy are indicative of patient outcomes	19
V130 – Robot-assisted excision and anastomosis for posterior urethral stricture via abdominoperineal approach	18
A0628 – Personalized prediction of five-year recurrence in prostate cancer post-focal therapy using machine learning approaches	18
P634 – Key factors affecting robotic vs. open radical cystectomy approach selection in non-muscle invasive and muscle invasive bladder cancer treatment: Insights from the 2021 national cancer database	18
P372 – Utilizing an artificial intelligence model with Masson's trichrome stained bladder biopsies to predict muscle invasion in bladder cancer	18